Saar Drugs LLP
About Saar Drugs LLP
Data last updated:
Saar Drugs LLP is a limited liability partnership (LLP) based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 2012 and has been in existence for over 14 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAA-7512. Its GSTIN is 21ACBFS1590C1ZO (Odisha). The LLP holds 3 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Rashmiranjan Samantaray and Sasmita Sahoo.
Its latest statement of accounts is for the year ended 31 March 2019. The registered office is at H.No. – 59 Vill Madangir, New, Delhi, India – 110062.
As per MCA filings, the LLP has open charges of ₹69 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No. – 59 Vill Madangir, New, Delhi, India – 110062
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Saar Drugs LLP
Saar Drugs has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmiranjan Samantaray Also directs: Aryanashi Consultanancy Services LLP, Sarax Lab Private Limited | Designated Partner | 03 Jan 2012 | 14 Years 9 Months | Current |
| Sasmita Sahoo Also directs: Aryanashi Consultanancy Services LLP, Sarax Lab Private Limited | Designated Partner | 03 Jan 2012 | 14 Years 9 Months | Current |
Financials of Saar Drugs LLP FY 2019 filings available
Financial Statement Summary of Saar Drugs LLP
| Statement of Account and Solvency | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Saar Drugs LLP
| Statement of Account and Solvency | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Saar Drugs are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Saar Drugs LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2016 | Yes Bank Limited | ₹69 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Saar Drugs LLP
Employment history and EPFO contributions of people linked to Saar Drugs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Saar Drugs LLP
Saar Drugs has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21ACBFS1590C1ZO | Odisha | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Saar Drugs LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Saar Drugs LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Saar Drugs LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Saar Drugs LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Saar Drugs LLP
Frequently Asked Questions about Saar Drugs LLP
Saar Drugs is an active limited liability partnership based in New, Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 03 January 2012 (14+ years old) and is registered under LLPIN AAA-7512.
Saar Drugs has 2 current designated partners:
- Rashmiranjan Samantaray - Designated Partner
- Sasmita Sahoo - Designated Partner
The GSTIN of Saar Drugs is 21ACBFS1590C1ZO, registered in Odisha. The LLP has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Saar Drugs is AAA-7512. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Saar Drugs was incorporated on 03 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The registered office of Saar Drugs is at H.No. – 59 Vill Madangir, New, Delhi, India – 110062.
The total obligation of contribution is ₹1 Lakh.
Saar Drugs operates in the pharma industry, in the drug formulation and development segment.
Saar Drugs has open charges of ₹69 Lakh and no satisfied charges on record as per latest MCA filings.